Skip to content
Search

Latest Stories

GPhC proposes new guidance for online pharmacies to improve patient safety

GPhC proposes new guidance for online pharmacies to improve patient safety

These proposed changes aim to address inappropriate supply of high-risk medicines by online pharmacies

The General Pharmaceutical Council (GPhC) is inviting feedback on proposed changes to its guidance for online pharmacies, aimed at enhancing patient safety.


These changes are designed to tackle concerns associated with receiving medicines from online pharmacies, particularly those that may not be clinically appropriate and could potentially harm patients.

GPhC has identified concerns relating to inappropriate supplies of weight loss medications  that could pose risk to patients' health.

Duncan Rudkin, Chief Executive of the GPhC, underscored the importance of addressing risks in online pharmacy services.

“We know that there can be significant benefits for people using online pharmacy services to get medicines and treatment, but there are also additional risks that need to be managed, to make sure medicines and other pharmacy services are provided safely to patients and the public.

“Through our inspections and investigations, we’ve seen significant risks to patient safety when online questionnaires have inappropriately been the only mode of consultation used, and when the information provided by the patient isn’t verified by the prescriber.”

The regulator is seeking views from stakeholders on the following key proposed changes:

  • Online pharmacies will be required to implement additional safety measures when prescribing or supplying medicines known to be associated with greater risks, such as those used for weight loss.
  • There should be a two-way communication channel between the patient and the prescriber for all online prescribing as some medicines are not suitable to be prescribed using an online questionnaire alone.
  • Prescribers will be given further instructions on how to verify patient information, especially for high-risk medicines. This may include conducting a direct consultation through a phone call or video chat, or by contacting the person’s GP.
  • Additional guidance will be provided for prescribers to follow in circumstances where patients lack a regular prescriber or have not consented to share their information with their GP.
  • Superintendent Pharmacists will be made jointly responsible with pharmacy owners for adhering to the new guidance.

Concerns about inappropriate supplies of medicines by online pharmacies were identified through GPhC inspections and enforcement action against online pharmacies, fitness to practise concerns raised with the regulator, and through working closely with other regulators.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less